Zymeworks Inc Q & A
Q: What’s the story about Zymeworks entering into a deal with Royalty Pharma?
A: Zymeworks and Royalty Pharma have already entered into $250 Million Royalty-Backed Note Financing.
Zymeworks (This content is for paid subscribers.
Exclusive Market Insight
& Scientific analysis
- Exclusive Posts
- Industry Newsletters
- Clinical Trials
- Possible Takeovers
- Technology of the Week
- Stock Table
- Therapeutic Vaccines
- Development-Stage Firms
- Genomics
- Prohost Picks
- And much more...
